Tech Company Financing Transactions
Ancora Heart Funding Round
On 7/21/2021, Ancora Heart raised $80 million in funding from Sands Capital Management, Savitr Capital and Sio Capital Management.
Transaction Overview
Company Name
Announced On
7/21/2021
Transaction Type
Venture Equity
Amount
$80,000,000
Round
Undisclosed
Proceeds Purpose
The latest investments will help us prepare for potential launch and subsequent commercialization.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4001 Burton Dr.
Santa Clara, CA 95054
USA
Santa Clara, CA 95054
USA
Phone
Website
Email Address
Overview
We are a medical device company based in Santa Clara, CA, dedicated to helping people with heart failure and functional mitral regurgitation (FMR) feel better and live longer. We developed AccuCinch, the first percutaneous ventricular repair (PVR) system designed to treat FMR, which is caused by heart failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Closs
Chief Technical Officer
Russel Sampson
Vice President
Christine Tjossem
VP - Marketing
Bart Beasley
VP - Regulatory Affairs
Michael Fritz
VP - Regulatory Affairs
Michael Zapien
Browse more venture capital transactions:
Prev: 7/21/2021: TMRW Life Sciences venture capital transaction
Next: 7/21/2021: MURAL by Tactivos venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs